08 January 2024
08 January 2024
The Phase III ASC4FIRST trial demonstrated improved molecular response rates compared to standard-of-care treatments.
Curevo’s shingles vaccine met all primary endpoints and was non-inferior to GSK’s Shingrix in a head-to-head Phase II trial.
The algorithm identifies eligible patients by extracting critical information from both structured and unstructured data sources.
The Clinical Trials Arena team also reviews assets in pain, infectious diseases and oncology.
The company aims to drive a small molecule resurgence with its lead Alzheimer’s symptom relief agent AD-101.
While also announcing a partnership with Foresight Diagnostics, Allogene will focus cema-cel’s use as a first-line consolidation therapy in lymphoma patients.
Assessing the safety of the combination regimen is the trial’s primary objective.
A reduction in weight is the primary outcome of the Phase IIa HuMAIN clinical trial.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
